We explored the relationship between DDX58 and immune cell infiltration in specific tumor patients and studied the potential role of DDX58 in tumor patients, we also analyzed the methylation profile of DDX58 promoter and the mutation of DDX58 in the UALCAN database. This evidence concerns the gene RIGI and neoplasm.